The infectious diseases diagnostics market was valued at USD 35.5 billion in 2021 and it is anticipated to grow further up to USD 30.9 billion by 2031, at a CAGR of -1.4% during the forecast period.
A contagious illness A diagnostic is a laboratory test carried out by trained technicians and medical professionals to identify infectious diseases. It is a diagnostic process used to characterize and identify the infectious disease’s causal organism. By using a variety of diagnostic techniques and tools, the sample of urine, blood, mucus, or other body fluids is examined to provide details on the causative organism.
Get Access to A Free Sample Copy of Our Latest Report – https://www.globalinsightservices.com/request-sample/GIS10304
Market Trends and Drivers
The market for infectious disease diagnostics will rise as a result of the prevalence of infectious diseases in both developed and emerging nations. The growing number of prescriptions for infectious illness diagnostic tests is due to the diagnosis and treatment of such disorders. The demand for infectious disease diagnostics is anticipated to increase during the projected period as a result of these factors and the expanding trend toward preventive medicine. The extensive population-based testing is necessary to enhance COVID-19 preventive and control activities. Since infectious disease diagnostics performs these tests, it had a favorable effect on this market.
Similarly, Major participants in the infectious illness diagnostics market are anticipated to have chances for expansion in emerging economies like India, South Korea, Brazil, and Mexico. This can be linked to the high disease prevalence, sizable patient population, expanding medical tourism, improving healthcare infrastructure, and rising disposable income in these nations. The Asia Pacific region has become a flexible and business-friendly hub because to fewer onerous rules and data requirements than the previously mentioned criteria.
Major Players in the Global Infectious Disease Diagnostics Market
The key players studied in the report are Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Siemens Healthineers AG (Germany), Danaher Corporation (US), Becton, Dickinson and Company (US), PerkinElmer, Inc. (US), Hologic, Inc. (US), QIAGEN N.V. (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), and Ortho Clinical Diagnostics Holdings plc (US), among others.
Get A Customized Scope to Match Your Need Ask an Expert – https://www.globalinsightservices.com/request-customization/GIS10304
COVID-19 Impact
The new coronavirus is the infectious disease known as COVID-19. Before the outbreak started in Wuhan, China, in December 2019, COVID-19 was largely unknown. In just a few weeks, it went from a local issue to a worldwide pandemic. On March 11, 2020, the World Health Organization (WHO) designated COVID-19 to be a pandemic. Government agencies from all over the world are assisting laboratories in expediting COVID-19 testing procedures because testing is still an essential step in slowing the disease’s rapid spread. Due to the employment of infectious disease diagnostic techniques for COVID-19 testing, the COVID-19 pandemic had a beneficial influence on the market for infectious illness diagnostics but had a negative impact on total sales for the majority of the companies.
Accordingly, regulatory agencies used techniques to hasten the licensing of COVID-19 diagnostic products. As diagnostic testing continues to be the foundation of the COVID-19 response, supporting containment efforts to reduce the outbreak, significant companies have also made strategic developments to deploy COVID-19 quick tests and neutralize the influence of COVID-19 on their operating capabilities. Additionally, due to the severity of the crisis and growing capacity problems with PCR-based testing, diagnostic solutions were developed more quickly to fulfill the demand for mass testing. Major players in this industry expanded their operations to test and monitor COVID-19.
Global Infectious Diseases Diagnostics Market Segmentation
By Product & Services
- Assays, Kits & Reagents
- Instruments
- Services & Software
By Technology
- Immunodiagnostics
- Clinical Microbiology
- Polymerase Chain Reaction
- Isothermal Nucleic Acid Amplification Technology
- DNA Sequencing and Next Generation Sequencing
- DNA Microarray
- Others
Buy Now – https://www.globalinsightservices.com/checkout/single_user/GIS10304
By Disease Type
- Hepatitis
- Human Immunodeficiency Virus
- Chlamydia Trachomatis Genital Infection & Gonorrhea
- Hospital Acquired Infections
- Human Papillomavirus
- Tuberculosis
- Influenza
- Others
By End Use
- Hospital/Clinical Laboratories
- Reference Laboratories
- Others
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1–833–761–1700
Website: https://www.globalinsightservices.com/